Biosimilars Access and Affordability Act has not moved since its introduction on Sep 28, 2026, with cosponsors from both parties
IntroducedSep 28, 2026
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary
CRS has not published a summary of this bill yet. Read the bill text.
Context
- Committees
- House Energy and Commerce Committee
House Ways and Means Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 1 of 69 bills enacted since 2013
- Text versions
- 1: introduced in house · 1,811 words
- Latest action
- Sep 28, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 1
Each bill appears once, under its strongest link. 1 in all.
Related, per CRS or House · 1
- 119th S. 5571 Biosimilars Access and Affordability Act R · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]